Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biolin Scientific Oy
OY
Active
Y-tunnus 0786529-3
Tietäjäntie 2, 02130
Espoo
Manufacture of instruments and appliances for measuring, testing and navigation
·
NACE 2651
Est. 1989 · 36 years old
— employees
Share
Finland
/
Companies
/
Manufacture of instruments and appliances for measuring, testing and navigation
/
Biolin Scientific Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
6M
5M
3M
2M
0M
2021: 4M
4M
2021
2022: 4M (0% vs 2021)
4M
0%
2022
2023: 5M (+25% vs 2022)
5M
+25%
2023
2024: 5M (0% vs 2023)
5M
0%
2024
2025: 4M (-20% vs 2024)
4M
-20%
2025
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
4 221
4 555
4 635
3 847
3 798
Staff expenses
−2 105
−1 945
−1 760
−1 299
−1 197
EBITDA
415
345
311
254
248
Depreciation & amort.
−13
−12
−10
−8
−2
EBIT
402
333
302
247
246
Net financials
18
24
−0
−2
−0
Profit before tax
420
357
301
245
246
Tax
87
73
−0
−0
−0
Net profit
333
283
301
245
246
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
3 475
3 203
2 773
2 381
2 227
Equity
2 545
2 212
1 929
1 627
1 383
Long-term debt
0
0
0
—
—
Short-term debt
930
991
845
754
845
Total debt
930
991
845
754
845
Financial ratios
5-year trend
EBITDA margin
9,8 %
This company
15,8 %
Market median
This company
Market median
38% below market
2021
2025
Equity ratio
73,2 %
This company
38,2 %
Market median
This company
Market median
92% above market
2021
2025
Return on equity
13,1 %
This company
18,4 %
Market median
This company
Market median
29% below market
2021
2025
Net profit margin
7,9 %
This company
8,1 %
Market median
This company
Market median
2% below market
2021
2025
Asset turnover
1,21×
This company
1,12×
Market median
This company
Market median
8% above market
2021
2025
Debt / equity
0,37×
This company
0,62×
Market median
This company
Market median
40% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Biolin Scientific Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
